The Mechanism of Kidney Disease due to APOL1 Risk Variants: Involvement of Two Distinct Processes.
作者信息
Pays Etienne
机构信息
Laboratory of Molecular Parasitology, IBMM, Université Libre de Bruxelles, Brussels, Belgium.
出版信息
J Am Soc Nephrol. 2024 Jun 1;35(6):818-821. doi: 10.1681/ASN.0000000000000367. Epub 2024 Apr 10.
Abstract
摘要
相似文献
1
The Mechanism of Kidney Disease due to APOL1 Risk Variants: Involvement of Two Distinct Processes.APOL1风险变异导致肾脏疾病的机制：两个不同过程的参与
J Am Soc Nephrol. 2024 Jun 1;35(6):818-821. doi: 10.1681/ASN.0000000000000367. Epub 2024 Apr 10.
2
Worldwide Frequencies of APOL1 Renal Risk Variants.载脂蛋白L1（APOL1）肾脏风险变异的全球频率。
N Engl J Med. 2018 Dec 27;379(26):2571-2572. doi: 10.1056/NEJMc1800748.
3
Variant upon variant: kidney-disease risk associated with APOL1 G2 genetic variants is abrogated by the APOL1 p.N264K variant.变体之上的变体：与APOL1 G2基因变体相关的肾脏疾病风险被APOL1 p.N264K变体消除。
Kidney Int. 2024 Sep;106(3):345-348. doi: 10.1016/j.kint.2024.03.030. Epub 2024 May 14.
4
Genetic Testing for Genetic Variants in Clinical Practice: Finally Starting to Arrive.临床实践中基因变异的基因检测：终于开始落地。
Clin J Am Soc Nephrol. 2020 Jan 7;15(1):126-128. doi: 10.2215/CJN.01810219. Epub 2019 Nov 18.
5
Bi- and Monoallelic Variants and Chronic Kidney Disease in West Africans.西非人的双等位基因和单等位基因变异与慢性肾脏病
N Engl J Med. 2025 Jan 16;392(3):228-238. doi: 10.1056/NEJMoa2404211. Epub 2024 Oct 26.
6
Kidney disease and APOL1.肾脏疾病与载脂蛋白L1。
Hum Mol Genet. 2021 Apr 26;30(R1):R129-R137. doi: 10.1093/hmg/ddab024.
7
Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease.APOL1 孔形成功能的遗传抑制可预防 APOL1 介导的肾脏疾病。
J Am Soc Nephrol. 2023 Nov 1;34(11):1889-1899. doi: 10.1681/ASN.0000000000000219. Epub 2023 Oct 6.
8
APOL1-associated kidney disease: modulators of the genotype-phenotype relationship.载脂蛋白L1相关肾病：基因型-表型关系的调节因子
Curr Opin Nephrol Hypertens. 2025 May 1;34(3):191-198. doi: 10.1097/MNH.0000000000001068. Epub 2025 Mar 6.
9
APOL1 nephropathy - a population genetics success story.APOL1 肾病——一个群体遗传学的成功案例。
Curr Opin Nephrol Hypertens. 2024 Jul 1;33(4):447-455. doi: 10.1097/MNH.0000000000000977. Epub 2024 Feb 28.
10
The Mechanism of Kidney Disease Due to APOL1 Risk Variants.APOL1风险变异导致肾脏疾病的机制。
J Am Soc Nephrol. 2020 Nov;31(11):2502-2505. doi: 10.1681/ASN.2020070954. Epub 2020 Sep 17.
引用本文的文献
1
Apolipoprotein L1 (APOL1): Consideration of Molecular Evolution, Interaction with APOL3, and Impact of Splice Isoforms Advances Understanding of Cellular and Molecular Mechanisms of Cell Injury.载脂蛋白L1（APOL1）：对分子进化、与APOL3相互作用以及剪接异构体影响的思考推动了对细胞损伤的细胞和分子机制的理解。
Cells. 2025 Jul 2;14(13):1011. doi: 10.3390/cells14131011.
2
Targeting the Type I Interferon Pathway in Glomerular Kidney Disease: Rationale and Therapeutic Opportunities.靶向肾小球肾病中的I型干扰素通路：原理与治疗机会
Kidney Int Rep. 2024 Oct 21;10(1):29-39. doi: 10.1016/j.ekir.2024.10.013. eCollection 2025 Jan.
本文引用的文献
1
Apolipoprotein L1 (APOL1) renal risk variant-mediated podocyte cytotoxicity depends on African haplotype and surface expression.载脂蛋白 L1 (APOL1) 肾脏风险变异介导的足细胞细胞毒性取决于非洲单倍型和表面表达。
Sci Rep. 2024 Feb 14;14(1):3765. doi: 10.1038/s41598-024-53298-4.
2
APOL1-mediated monovalent cation transport contributes to APOL1-mediated podocytopathy in kidney disease.APOL1 介导的单价阳离子转运有助于 APOL1 介导的肾脏病中的足细胞病变。
J Clin Invest. 2024 Jan 16;134(5):e172262. doi: 10.1172/JCI172262.
3
Apolipoproteins L1 and L3 control mitochondrial membrane dynamics.载脂蛋白 L1 和 L3 控制线粒体膜动态。
Cell Rep. 2023 Dec 26;42(12):113528. doi: 10.1016/j.celrep.2023.113528. Epub 2023 Dec 2.
4
Cholesterol and PIP Modulation of BK Channels.胆固醇和 PIP 对 BK 通道的调节。
Adv Exp Med Biol. 2023;1422:217-243. doi: 10.1007/978-3-031-21547-6_8.
5
The bidirectional link between HDL and COVID-19 infections.高密度脂蛋白（HDL）与新型冠状病毒肺炎（COVID-19）感染之间的双向联系。
J Lipid Res. 2021;62:100067. doi: 10.1016/j.jlr.2021.100067. Epub 2021 Mar 17.
6
APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of Actomyosin.APOL1 C 末端变异体可能通过干扰 APOL3 对肌动球蛋白的控制引发肾脏疾病。
Cell Rep. 2020 Mar 17;30(11):3821-3836.e13. doi: 10.1016/j.celrep.2020.02.064.
7
Emerging Roles of Neuronal Ca Sensor-1 in Cardiac and Neuronal Tissues: A Mini Review.神经元钙传感器-1在心脏和神经组织中的新作用：一篇综述短文
Front Mol Neurosci. 2019 Mar 4;12:56. doi: 10.3389/fnmol.2019.00056. eCollection 2019.
8
A null variant in the apolipoprotein L3 gene is associated with non-diabetic nephropathy.载脂蛋白 L3 基因中的一个无效变体与非糖尿病肾病有关。
Nephrol Dial Transplant. 2018 Feb 1;33(2):323-330. doi: 10.1093/ndt/gfw451.
9
Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.足细胞中人类APOL1风险变异体的转基因表达可诱发小鼠肾病。
Nat Med. 2017 Apr;23(4):429-438. doi: 10.1038/nm.4287. Epub 2017 Feb 20.
10
Large-Conductance Calcium-Activated Potassium Channels in Glomerulus: From Cell Signal Integration to Disease.肾小球中的大电导钙激活钾通道：从细胞信号整合到疾病
Front Physiol. 2016 Jun 21;7:248. doi: 10.3389/fphys.2016.00248. eCollection 2016.
Zotero 插件